Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04094753
Other study ID # EC/2013/950
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2014
Est. completion date August 1, 2024

Study information

Verified date January 2024
Source University Hospital, Ghent
Contact Kim Pauwaert, MD
Phone +32 093321182
Email kim.pauwaert@uzgent.be
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Urinary incontinence is an increasing medical and socio-economical problem. 44% of the elderly (>65 years) women and 28% of the elderly men suffer from unwilling urine loss. Moreover, this percentages increase with age. Incontinence is a problem with multiple physical, psychological, and financial effects. In addition incontinence has a important impact on the family and healthcare professionals surrounding the elderly. The problem of urinary incontinence is complex and multifactorial. Moreover, diagnostic guidelines are inconsistent leading to a high amount of technical interventions to diagnose and to specify the type of incontinence. Aim of this study is to create a short form of necessary technical investigations to diagnose and evaluate urinary incontinence.


Recruitment information / eligibility

Status Recruiting
Enrollment 202
Est. completion date August 1, 2024
Est. primary completion date August 1, 2024
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - >= 65 years - Every type of incontinence: stress, urge, mixed. Exclusion Criteria: - Patients with an indwelling urinary catheter are doing clean intermittent catheterization are excluded from the study protocol - Patients with dementia are excluded from the study, based on N-Cog evaluation

Study Design


Intervention

Diagnostic Test:
Blood Sample
A sober blood sample is taken to observe the following parameters: creatinin, ureum, sodium, potassium, osmolality, HDL cholesterol, LDL cholesterol, triglycerides)
Renal Function Profile
A Renal Function Profile is a 24 hour-urine collection in which urine samples are collected at fixed time points every 3 hours, starting 3 hours after the first morning void. Daytime samples were taken at 10:00-11:30 (U1), 13:00-15:30 (U2), 16:00-17:30 (U3), 19:00-20:30 (U4), and 22:00-23:30 (U5). The nighttime samples were taken at 1:00-2:30 (U6), 4:00-5:30 (U7) and 7:00-8:30 (U8). The volume of each sample, and of each micturition in between, was noted to calculate the 24h, daytime and nighttime urine volume and diuresis rate.
Frequency Volume Chart
Every patient complets a frequency volume chart during 24 of 72 hours
Cystometry
This technique provide the most precise measurement of bladder and urethral sphincter behaviour during bladder filling and during voiding.
Questionaires
Patients have to fulfill the following questionaires ICIQ-Fluts for female participants or ICIQ-Mluts for male participants TILBURG FRAILTY INDICATOR SF-36 Quality of Life score N- QOL
Flow rate measurement + Observation of the post-void residual urine volume
A measurement of the urinary flow rate is observed to collect the maximum Q/s. Afterwards an observation of the PVR is done using ultrasound.
Clinical Examination
Clinical examination of the genital region. For women, coeles are described using the POPQ

Locations

Country Name City State
Belgium Department of Urology, Ghent University Hospital Gent

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Ghent

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Decreasing the amount of necessary technical investigations to diagnose incontinence Based on international guidelines different technical investigations are used and approved to observe the type of urinary incontinence individually. Nevertheless, based on expert opinion all technical investigations schould be done together. However this combination of different technical investigations (urodynamics, questionaires, voiding dairy and clinical examination) is not evidence based and time consuming. We want to develop a statistical model to decrease the need of technical investigations to obtain a correct diagnose of stress urinary incontinence, urge urinary incontinence or mixed incontinence. 1 month
See also
  Status Clinical Trial Phase
Completed NCT05058326 - Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
Recruiting NCT04305743 - Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A Phase 4
Recruiting NCT05362292 - TReating Incontinence for Underlying Mental and Physical Health Phase 4
Active, not recruiting NCT06247033 - Efficacies of Different Managements in Patients With Overactive Bladder With Stroke N/A
Withdrawn NCT03753750 - Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder N/A
Not yet recruiting NCT05892575 - The Effect of Incontinence Program Applied to Obese Elderly on Quality of Life, Coping and Loneliness N/A
Completed NCT03615001 - T-DOC® NXT Clinical Investigation N/A
Completed NCT03429270 - T-DOC® 5 Fr Pediatric Clinical Investigation N/A
Completed NCT03817931 - Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder Phase 4
Not yet recruiting NCT05948397 - To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence